Monday, December 23, 2024
HomeTagsKRAS inhibitor

KRAS inhibitor

Journal of Clinical Oncology Publishes Rapid Communication Featuring Updated Clinical Data for Adagrasib as a Targeted Treatment for KRASG12C-Mutated Advanced Solid Tumors

Mirati Therapeutics, Inc., a commercial stage biotechnology company, announced the Journal of Clinical Oncology published in a Rapid Communication data indicating adagrasib, a potent and selective...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics